News - tafamidis


Current filters:


Popular Filters

FDA advisory panel gives mixed views on Pfizer's tafamidis


The US Food and Drug Administration's peripheral and Central Nervous System Drugs Advisory Committee…

North AmericaPfizerPharmaceuticalRare diseasesRegulationtafamidisVyndaqel

FDA expands Levemir use to young children; negative on tafamidis


Denmark-based global insulin giant Novo Nordisk (NOV: N) says that the US Food and Drug Administration…

DiabetesLevemirNorth AmericaNovo NordiskPfizerPharmaceuticalRare diseasesRegulationtafamidisVyndaqel

FDA now accepts Pfizer’s tafamidis NDA


Having around a year ago issued a refuse to file letter (The Pharma Letter April 5, 2011), the US Food…

North AmericaPfizerPharmaceuticalRare diseasesRegulationtafamidisVyndaqel

Pfizer’s Vyndaqel, first drug to treat rare and fatal disease TTR-FAP, approved in Europe


Following a positive opinion from an advisory committee in the summer (The Pharma Letter July 23), the…

EuropePfizerPharmaceuticalRare diseasesRegulationtafamidisVyndaqel

Back to top